Therapeutic options for persistent asthma

被引：2

作者：

Holgate, ST ^{[1
]}

机构：

[1] Univ Southampton, Sch Med, Resp Cell & Mol Biol Div, Southampton SO16 6YD, Hants, England

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2001年 / 285卷 / 20期

关键词：

D O I：

10.1001/jama.285.20.2637

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2637 / 2639

页数：3

共 26 条

[1]

[Anonymous], 1998, NIH PUBL

[2] Asthma - From bronchoconstriction to airways inflammation and remodeling [J].

Bousquet, J ;

Jeffery, PK ;

Busse, WW ;

Johnson, M ;

Vignola, AM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (05) :1720-1745

[3] SALMETEROL XINAFOATE AS MAINTENANCE THERAPY COMPARED WITH ALBUTEROL IN PATIENTS WITH ASTHMA [J].

DALONZO, GE ;

NATHAN, RA ;

HENOCHOWICZ, S ;

MORRIS, RJ ;

RATNER, P ;

RENNARD, SI .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (18) :1412-1416

[4] Effect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects [J].

Dente, FL ;

Bancalari, L ;

Bacci, E ;

Bartoli, ML ;

Carnevali, S ;

Cianchetti, S ;

Di Franco, A ;

Giannini, D ;

Vagaggini, B ;

Testi, R ;

Paggiaro, PL .

THORAX, 1999, 54 (07) :622-624

[5] Ligand-independent activation of the glucocorticoid receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells [J].

Eickelberg, O ;

Roth, M ;

Lörx, R ;

Bruce, V ;

Rüdiger, J ;

Johnson, M ;

Block, LH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) :1005-1010

[6] Epithelial-mesenchymal interactions in the pathogenesis of asthma [J].

Holgate, ST ;

Davies, DE ;

Lackie, PM ;

Wilson, SJ ;

Puddicombe, SM ;

Lordan, JL .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (02) :193-204

[7] Long-acting β2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma -: A randomized controlled trial [J].

Lazarus, SC ;

Boushey, HA ;

Fahy, JV ;

Chinchilli, VM ;

Lemanske, RF ;

Sorkness, CA ;

Kraft, M ;

Fish, JE ;

Peters, SP ;

Craig, T ;

Drazen, JM ;

Ford, JG ;

Israel, E ;

Martin, RJ ;

Mauger, EA ;

Nachman, SA ;

Spahn, JD ;

Szefler, SJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (20) :2583-2593

[8] Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial [J].

Lemanske, RF ;

Sorkness, CA ;

Mauger, EA ;

Lazarus, SC ;

Boushey, HA ;

Fahy, JV ;

Drazen, JM ;

Chinchilli, VM ;

Craig, T ;

Fish, JE ;

Ford, JG ;

Israel, E ;

Kraft, M ;

Martin, RJ ;

Nachman, SA ;

Peters, SP ;

Spahn, JD ;

Szefler, SJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (20) :2594-2603

[9] Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids [J].

Leuppi, JD ;

Salome, CM ;

Jenkins, CR ;

Anderson, SD ;

Xuan, W ;

Marks, GB ;

Koskela, H ;

Brannan, JD ;

Freed, R ;

Andersson, M ;

Chan, HK ;

Woolcock, AJ .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (02) :406-412

[10] An antiinflammatory effect of salmeterol, a long-acting β2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma [J].

Li, X ;

Ward, C ;

Thien, F ;

Bish, R ;

Bamford, T ;

Bao, XH ;

Bailey, M ;

Wilson, JW ;

Walters, EH .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (05) :1493-1499

← 1 2 3 →